Inicio › Cáncer de pulmón de células no pequeñas › Nueva York › Rochester
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Rochester, NY
13 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Rochester y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Rochester General Hospital, Rochester
- University of Rochester, Rochester
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
ReclutandoFase 3
- Wilmot Cancer Institute ( Site 0141), Rochester
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
ReclutandoFase 3
- Research Site, Rochester
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
ReclutandoFase 3
- University of Rochester Medical Center, Rochester
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
ReclutandoFase 2/3
- Rochester General Hospital Infectious Disease, Rochester
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
ReclutandoFase 3
- University of Rochester, Rochester
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
ReclutandoSe aceptan voluntarios sanos
- University of Rochester, Rochester
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
ReclutandoFase 3
- University of Rochester Medical Center, Rochester
Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
ReclutandoFase 1
- University of Rochester, Rochester
- University of Rochester, Rochester
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- University of Rochester, Rochester
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- University of Rochester, Rochester
- Wilmot Cancer Institute at Webster, Webster · A 10 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- University of Rochester, Rochester
Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
ReclutandoFase 2
- University of Rochester, Rochester
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Rochester
- Leucemia mielógena aguda16 estudios
- Cáncer de pulmón15 estudios
- Cáncer de seno15 estudios
- Cáncer (todos los tipos)14 estudios
- Obesidad14 estudios
- Sobrepeso13 estudios
- Cáncer de próstata10 estudios
- Cáncer metastásico8 estudios
- Mieloma múltiple8 estudios
- Cáncer de vejiga7 estudios
- Distrofia miotónica7 estudios
- Cáncer de páncreas7 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.